To our knowledge, the current meta-analysis firstly elucidated the potential association between the FABP2 Ala54Thr polymorphisms and T2DM risk based on a Human Genome Epidemiology review of all research published up to April, 2014. This evidence concerns the gene FABP2 and type 2 diabetes mellitus.